OncoInv

Worldwide each year, 19.3 million people are diagnosed with cancer and the numbers are growing. Nearly 1 in 6 deaths is caused by cancer. The need to expedite diagnosis is vital. Early diagnosis increases chances of survival and reduces the negative impact on quality of life. OncoInv offers OncoSeek®, a multi-cancer early detection blood test.

OncoSeek® is a software based early detection test, which analyses the concentrations of a selected number of protein tumor markers with a Machine Learning algorithm. It performs detection of 9 high-mortality cancers, calculating a Probability of Cancer score as wel as a predicted Tissue of Origin. OncoSeek® is scientifically validated, CE-marked and can be easily implemented as it uses existing medical infrastructure.

OncoSeek® can be used anywhere in the world by medical organisations who provide health services to the public.